World class capabilities
in cell and gene technologies
Stevenage Bioscience Catalyst is a leading location for companies to develop and commercialise cutting edge therapeutics.
Companies based at the Stevenage Campus employ over 3,500 people. The Campus is home to major organisations including GSK, the Cell and Gene Therapy Manufacturing Catapult, LifeArc and Cytiva alongside a growing cluster of start-up companies which together have raised over £3bn in funding.
Located within the golden triangle and the academic centres of London, Cambridge and Oxford, SBC is ideally positioned for the translation and scale-up of cutting edge innovation.
The SBC team have been an invaluable source of support over
the years, particularly during the pandemic and subsequent
lockdown. Innovative SMEs in the UK bioscience space could
not flourish without the right supportive infrastructure,
something SBC have excelled at.
Prof. Mo Alavijeh FRSC FRSM, Managing Director, Pharmidex
The SBC team have been an invaluable source of support over the years, particularly during the pandemic and subsequent lockdown. Innovative SMEs in the UK bioscience space could not flourish without the right supportive infrastructure,
something SBC have excelled at.
Prof. Mo Alavijeh FRSC FRSM, Managing Director, Pharmidex
An exciting, knowledgeable, and collegiate community
The vibrant ecosystem is based on bringing together a range of organisations throughout the innovation pipeline from start-ups to major multinationals. This has created an exciting, knowledgeable and collegiate community where interaction and collaboration are the norm.
Organisations joining the campus must have a focus on research, products or technologies that are relevant to the therapeutics industry and protected by a strong IP portfolio.
SBC-based companies added a gross GVA of £87m (£34m net GVA) p.a. to the UK economy in 2020
SBC-based companies are predicted to contribute £417m gross GVA (£165m net GVA) p.a. to the UK economy by 2040
Bioscience companies say the support from SBC and its location have enabled them to reduce product development time by an average of nine months
Between 2017 and 2020, Stevenage, Cambridge, Oxford and London raised similar levels of biotech equity investment but the average deal size in Stevenage was more than five times greater
A supportive environment that adds value to your organisation and staff
By working directly with the major organisations on the campus and by providing shared facilities, a supportive environment has been created that delivers access to specialist scientific facilities, business support and mentoring from senior managers with the relevant scientific and commercialisation expertise.
The facilities have been designed to foster cooperation, scientific and commercial dialogue and interaction between entrepreneurs. Access is offered to business support, equipment and facilities that would otherwise be beyond the reach of small or medium-sized companies.
